Narrowed FY26 Revenue Outlook to $5.2B-$5.35B
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3d ago
0mins
Should l Buy MMS?
Narrows FY26 revenue view to $5.2B-$5.35B from $5.23B-$5.43B, consensus $5.47B.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MMS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MMS
About MMS
Maximus, Inc. is an operator of government health and human services programs and provider of technology solutions to governments. The Company operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment provides a variety of business process services (BPS), such as program administration, appeals and assessments, and related consulting work for United States state and local government programs. The U.S. Federal Services segment delivers end-to-end solutions that help various United States federal government agencies, including program operations and management, clinical services, and technology solutions. The Outside the U.S. segment provides BPS for international governments and commercial clients. The services of this segment include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. It also delivers services in the United Kingdom.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Maximus Reports Q1 2026 Earnings with Raised Guidance and Strong Pipeline
- Performance Stability: Maximus reported $1.35 billion in revenue for Q1 2026, a 4.1% decline year-over-year; however, CEO Bruce L. Caswell emphasized that the contract portfolio remained unaffected by last fall's shutdown, demonstrating the company's resilience in essential programs.
- Guidance Upward Revision: The company updated its fiscal year 2026 revenue guidance to between $5.2 billion and $5.35 billion, reflecting confidence in future growth, while adjusted EPS guidance was raised to a range of $8.05 to $8.35, indicating over 11% year-over-year growth.
- Technological Innovation: Maximus launched the AI-powered
See More
Maximus Reports Increased Net Income Despite Revenue Decline
- Net Income Growth: Maximus reported a net income of $93.94 million for Q1 FY2026, significantly up from $41.1 million last year, indicating successful cost control and operational efficiency.
- Earnings Per Share Increase: Adjusted EPS rose to $1.85 from $1.61 last year, surpassing analysts' expectations of $1.82, reflecting enhanced profitability.
- Revenue Decline: Despite the increase in net income, revenue fell to $1.35 billion from $1.40 billion year-over-year, primarily impacted by the divestiture of the U.S. Services Segment, highlighting market challenges.
- Optimistic Outlook: The company raised its FY2026 EPS guidance to a range of $8.05 to $8.35 and expects revenue between $5.2 billion and $5.35 billion, demonstrating management's confidence in future performance.
See More
MAXIMUS Q1 Earnings Beat Expectations Amid Revenue Miss
- Earnings Beat: MAXIMUS reported a Q1 non-GAAP EPS of $1.85, exceeding expectations by $0.03, indicating stable profitability despite a decline in overall revenue.
- Slight Revenue Decline: The company’s Q1 revenue was $1.35 billion, down 3.6% year-over-year, missing market expectations by $20 million, reflecting increased market competition and the impact of a recent divestiture.
- Guidance Update: MAXIMUS narrowed its revenue guidance for fiscal 2026, expecting full-year revenue to range between $5.2 billion and $5.35 billion, below the consensus of $5.47 billion, indicating a cautious outlook on future market conditions.
- Earnings Outlook Raised: The company raised its adjusted EBITDA margin expectation by 30 basis points to approximately 14%, and now expects adjusted diluted EPS to range between $8.05 and $8.35, reflecting confidence in improving profitability.
See More
Maximus Raises Earnings Outlook on Resilient Performance and Strong Pipeline
- Financial Performance Overview: Maximus reported first-quarter revenue of $1.35 billion for fiscal year 2026, a 4.1% decrease from the prior year, yet diluted earnings per share rose to $1.70 from $0.69, indicating strong performance in government services.
- Earnings Guidance Raised: The company has adjusted its fiscal year 2026 revenue guidance to between $5.2 billion and $5.35 billion, while also raising its adjusted diluted earnings per share forecast to a range of $8.05 to $8.35, reflecting confidence in future performance and sustained market demand.
- Cash Flow and Dividends: Operating cash flow for the first quarter was a negative $244 million; however, the company declared a quarterly cash dividend of $0.33 per share, demonstrating a commitment to shareholder returns despite challenges in cash flow management.
- Strong Sales Pipeline: As of December 31, 2025, Maximus's sales pipeline totaled $59.1 billion, with new work opportunities representing approximately 59%, indicating a robust outlook for contract acquisition and market expansion in the future.
See More
MAXIMUS Scheduled to Announce Q1 Earnings on February 5
- Earnings Announcement Date: MAXIMUS (MMS) is set to release its Q1 2023 earnings on February 5 before market open, with a consensus EPS estimate of $1.82, reflecting a 13% year-over-year growth that indicates sustained profitability.
- Revenue Expectations: The revenue estimate stands at $1.37 billion, representing a 2.1% decline year-over-year, which may suggest competitive pressures in the market, necessitating a strategic focus on recovery for future growth.
- Historical Performance Review: Over the past two years, MAXIMUS has beaten EPS estimates 75% of the time and revenue estimates 88% of the time, showcasing the company's financial stability and effective management practices.
- Forecast Revision Trends: In the last three months, EPS estimates have seen two upward revisions with no downward adjustments, while revenue estimates experienced one downward revision, indicating fluctuating market confidence in the company's future earnings potential, warranting close attention to the upcoming earnings report for its implications.
See More
CMS Reports That Companies Choosing to Participate Include Accenture, Acentra Health, Conduent, GDIT, Deloitte, Gainwell, Maximus, and Curam by Merative
Participating Companies: Several companies, including Accenture, Acentra Health, and Deloitte, are voluntarily participating in a collaborative initiative.
Focus Areas: The initiative aims to address key health and wellness issues, with a focus on improving outcomes and enhancing community health.
See More
Maximus Reports Q1 2026 Earnings with Raised Guidance and Strong Pipeline
- Performance Stability: Maximus reported $1.35 billion in revenue for Q1 2026, a 4.1% decline year-over-year; however, CEO Bruce L. Caswell emphasized that the contract portfolio remained unaffected by last fall's shutdown, demonstrating the company's resilience in essential programs.
- Guidance Upward Revision: The company updated its fiscal year 2026 revenue guidance to between $5.2 billion and $5.35 billion, reflecting confidence in future growth, while adjusted EPS guidance was raised to a range of $8.05 to $8.35, indicating over 11% year-over-year growth.
- Technological Innovation: Maximus launched the AI-powered
See More
Maximus Reports Increased Net Income Despite Revenue Decline
- Net Income Growth: Maximus reported a net income of $93.94 million for Q1 FY2026, significantly up from $41.1 million last year, indicating successful cost control and operational efficiency.
- Earnings Per Share Increase: Adjusted EPS rose to $1.85 from $1.61 last year, surpassing analysts' expectations of $1.82, reflecting enhanced profitability.
- Revenue Decline: Despite the increase in net income, revenue fell to $1.35 billion from $1.40 billion year-over-year, primarily impacted by the divestiture of the U.S. Services Segment, highlighting market challenges.
- Optimistic Outlook: The company raised its FY2026 EPS guidance to a range of $8.05 to $8.35 and expects revenue between $5.2 billion and $5.35 billion, demonstrating management's confidence in future performance.
See More
MAXIMUS Q1 Earnings Beat Expectations Amid Revenue Miss
- Earnings Beat: MAXIMUS reported a Q1 non-GAAP EPS of $1.85, exceeding expectations by $0.03, indicating stable profitability despite a decline in overall revenue.
- Slight Revenue Decline: The company’s Q1 revenue was $1.35 billion, down 3.6% year-over-year, missing market expectations by $20 million, reflecting increased market competition and the impact of a recent divestiture.
- Guidance Update: MAXIMUS narrowed its revenue guidance for fiscal 2026, expecting full-year revenue to range between $5.2 billion and $5.35 billion, below the consensus of $5.47 billion, indicating a cautious outlook on future market conditions.
- Earnings Outlook Raised: The company raised its adjusted EBITDA margin expectation by 30 basis points to approximately 14%, and now expects adjusted diluted EPS to range between $8.05 and $8.35, reflecting confidence in improving profitability.
See More
Maximus Raises Earnings Outlook on Resilient Performance and Strong Pipeline
- Financial Performance Overview: Maximus reported first-quarter revenue of $1.35 billion for fiscal year 2026, a 4.1% decrease from the prior year, yet diluted earnings per share rose to $1.70 from $0.69, indicating strong performance in government services.
- Earnings Guidance Raised: The company has adjusted its fiscal year 2026 revenue guidance to between $5.2 billion and $5.35 billion, while also raising its adjusted diluted earnings per share forecast to a range of $8.05 to $8.35, reflecting confidence in future performance and sustained market demand.
- Cash Flow and Dividends: Operating cash flow for the first quarter was a negative $244 million; however, the company declared a quarterly cash dividend of $0.33 per share, demonstrating a commitment to shareholder returns despite challenges in cash flow management.
- Strong Sales Pipeline: As of December 31, 2025, Maximus's sales pipeline totaled $59.1 billion, with new work opportunities representing approximately 59%, indicating a robust outlook for contract acquisition and market expansion in the future.
See More
MAXIMUS Scheduled to Announce Q1 Earnings on February 5
- Earnings Announcement Date: MAXIMUS (MMS) is set to release its Q1 2023 earnings on February 5 before market open, with a consensus EPS estimate of $1.82, reflecting a 13% year-over-year growth that indicates sustained profitability.
- Revenue Expectations: The revenue estimate stands at $1.37 billion, representing a 2.1% decline year-over-year, which may suggest competitive pressures in the market, necessitating a strategic focus on recovery for future growth.
- Historical Performance Review: Over the past two years, MAXIMUS has beaten EPS estimates 75% of the time and revenue estimates 88% of the time, showcasing the company's financial stability and effective management practices.
- Forecast Revision Trends: In the last three months, EPS estimates have seen two upward revisions with no downward adjustments, while revenue estimates experienced one downward revision, indicating fluctuating market confidence in the company's future earnings potential, warranting close attention to the upcoming earnings report for its implications.
See More
CMS Reports That Companies Choosing to Participate Include Accenture, Acentra Health, Conduent, GDIT, Deloitte, Gainwell, Maximus, and Curam by Merative
Participating Companies: Several companies, including Accenture, Acentra Health, and Deloitte, are voluntarily participating in a collaborative initiative.
Focus Areas: The initiative aims to address key health and wellness issues, with a focus on improving outcomes and enhancing community health.
See More
